Product NDC: | 52244-429 |
Proprietary Name: | Robaxin |
Non Proprietary Name: | Methocarbamol |
Active Ingredient(s): | 500 mg/1 & nbsp; Methocarbamol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52244-429 |
Labeler Name: | Actient Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011011 |
Marketing Category: | NDA |
Start Marketing Date: | 20120515 |
Package NDC: | 52244-429-10 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (52244-429-10) |
NDC Code | 52244-429-10 |
Proprietary Name | Robaxin |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (52244-429-10) |
Product NDC | 52244-429 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methocarbamol |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120515 |
Marketing Category Name | NDA |
Labeler Name | Actient Pharmaceuticals, LLC |
Substance Name | METHOCARBAMOL |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |